Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
NewsIndia's Maxivision Super Specialty Eye Hospitals has quietly filed for an IPO, signaling growing investor appetite in the country's booming eye-care sector. Backed by Quadria Capital, the 90-plus center chain has tapped ICICI Securities and IIFL Capital as bankers. India's eye-care market is on track to more than double — from $12.8 billion in 2025 to $31.2 billion by 2033.
India's Maxivision Super Specialty Eye Hospitals, backed by healthcare-focused private equity firm Quadria Capital, has confidentially filed for an initial public offering (IPO) — a move that underscores the surging investor interest in India's eye-care space. The filing was made through India's confidential submission mechanism, which lets companies seek regulatory approval without publicly disclosing financial or operational details upfront.
Founded in 1996, Maxivision operates more than 90 centers across six Indian states, competing with established players like Dr. Agarwal's Health Care, Centre for Sight, and ASG Eye Hospitals. Reuters had previously reported in July that the chain appointed ICICI Securities and IIFL Capital as bankers, with the IPO expected to include a mix of new share issuances and secondary sales by existing investors.
By the Numbers:
Why it matters: India's eye-care sector is on a steep growth trajectory, and Maxivision's IPO move reflects broader consolidation and capital-raising trends in specialty healthcare. For ophthalmology stakeholders, this signals expanding infrastructure and increased competition in one of the world's largest patient markets.